UPDATE: JPMorgan Upgrades Teva Pharma (TEVA) to Neutral

November 12, 2019 4:30 AM EST Send to a Friend
(Updated - November 12, 2019 4:53 AM EST)

(update comment)JPMorgan analyst Chris Schott upgraded Teva Pharma (NYSE: TEVA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login